Elotuzumab: a novel anti-CS1 monoclonal antibody for the treatment of multiple myeloma

Author: Lonial Sagar   Kaufman Jonathan   Laubach Jacob   Richardson Paul  

Publisher: Informa Healthcare

ISSN: 1471-2598

Source: Expert Opinion on Biological Therapy, Vol.13, Iss.12, 2013-12, pp. : 1731-1740

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract